NewAmsterdam Announces Appointment of David Topper as Chief

NAARDEN, the Netherlands and MIAMI, Dec. 19, 2022 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq:NAMS or “NewAmsterdam” or the “Company”),...

Related Keywords

Miami ,Florida ,United States ,Morningside ,Netherlands ,Russia ,Naarden ,Noord Holland ,Ukraine ,Carmen Lopez ,Louise Kooij ,Michael Davidson ,Hannah Deresiewicz ,John Kastelein ,Morgan Stanley ,Termgrid Inc ,Equity Commitment Committee ,Neither The Company ,Stanford Graduate School Of Business ,Portfolio Committee ,Nasdaq ,Newamsterdam Pharma Companynv Nasdaq ,Circleup Network Inc ,Senior Advisor To Frazier Life Sciences ,Commitments Committee ,Menarini Group ,Duke University ,Frazier Lifesciences Acquisition Corporation ,David Topper ,Chief Financial Officer ,Capital Markets ,Frazier Healthcare Partners ,Board Director ,Chief Accounting Officer ,Operating Partner ,General Atlantic ,Equity Capital Markets ,Managing Director ,Equity Commitment ,Debt Capital Markets ,Leveraged Finance ,Stanford Graduate School ,Senior Advisor ,Frazier Life Sciences ,Circleup Network ,Chief Scientific Officer ,Morningside Ventures ,Investor Relations ,Nasdaq Nams ,Ewamsterdam Pharma Companybv ,